Apply the peel-off label from the package insert to the infusion bag. 6 No clinical studies evaluating the drug interaction potential of mosunetuzumab-axgb
Healthcare professionals should refer to HSA's website for the latest approved package insert for the product. Mosunetuzumab. Lunsumio.
package insert on or associated with the container. Suitable containers A kit, comprising: (a) a first container comprising mosunetuzumab; and (b)
D Drug Mosunetuzumab (USAN/INN); Mosunetuzumab (genetical recombination) (JAN); Mosunetuzumab-axgb; Lunsumio (TN) LUNSUMIO (Genentech).
mosunetuzumab-axgb respectively. Cycle 2 Day 1 administer 60 mg of Briumvi (ublituximab-xiiy) injection package insert. Morrisville, NC: TG.
by NH Fowler 2024 Cited by 1Lunsumio (mosunetuzumab) [package insert]. South San Francisco (CA): Genentech, Inc.; 2024. Yescarta (axicabtagene ciloleucel) [package insert]
Lunsumio [package insert]. Referenced with permission from the NCCN Drugs and Biologics Compendium (NCCN Compendium) mosunetuzumab.
by L Iovino 2024 Cited by 61 Yescarta (axicabtagene ciloleucel) [package insert]. Kite Pharma Mosunetuzumab, a full-length bispecific CD20/CD3 antibody
Pradaxa package insert Eliquis package insert Xarelto package insert Authors concluded that the difference between the 2 devices was
I would like to know more about this package. ^.^